Gold Standard Phantoms Showcases MRI Calibration Technology at Launch of National Prostate Cancer Screening Report in the UK Parliament
Gold Standard Phantoms joined leaders at the House of Commons for the launch of Prostate Cancer Research’s landmark report on prostate screening. The company presented its METRION platform, a breakthrough in MRI calibration that enables accurate, standardised imaging to improve diagnosis and monitoring in prostate cancer care.
This week, Gold Standard Phantoms (GSP) had the privilege of attending the launch of Prostate Cancer Research’s new report on prostate screening, held at the UK House of Commons. The event brought together leaders from healthcare, research, and technology to discuss the future of prostate cancer detection and the vital role of innovation in saving lives.
GSP attended as part of its collaboration with Proven Connect, following their recent investment to support the rollout of GSP’s breakthrough METRION technology, designed to calibrate MRI scans for prostate cancer at the point of imaging.
In his keynote address, former Prime Minister Rishi Sunak, ambassador for the charity, described MRI as a “game changer” for prostate cancer screening, emphasising that “innovation is key” to delivering effective and equitable early detection across the UK.
This message resonates strongly with Gold Standard Phantoms’ mission. The company’s METRION platform introduces real-time calibration of MRI scans, ensuring that quantitative biomarkers, such as the Apparent Diffusion Coefficient (ADC), are consistent across scanners, hospitals, and timepoints. This standardisation is essential to improving diagnostic accuracy and ensuring patients receive the right treatment at the right time.
By embedding calibration directly into clinical workflows, METRION enables healthcare providers to confidently track disease progression in men under active surveillance, reducing unnecessary biopsies and over-treatment, while ensuring timely intervention when cancer becomes clinically significant.
Gold Standard Phantoms is proud to contribute to the next generation of precision imaging technologies that will make MRI a reliable, reproducible, and scalable tool for cancer screening and beyond.
Learn more about CARE™ and our mission to make MRI quantitative, standardised, and AI-ready at https://goldstandardphantoms.com/products/metrion